Galldiks, Norbert ORCID: 0000-0002-2485-1796, Lohmann, Philipp ORCID: 0000-0002-5360-046X, Werner, Jan-Michael ORCID: 0000-0001-7147-4594, Ceccon, Garry, Fink, Gereon R. ORCID: 0000-0002-8230-1856 and Langen, Karl-Josef ORCID: 0000-0003-1101-5075 (2020). Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors. Expert Rev. Anticancer Ther, 20 (1). S. 9 - 16. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-8328

Full text not available from this repository.

Abstract

Introduction: Currently, immunotherapy using vaccination strategies or oncolytic virus approaches, cell-based immunotherapy, and the blockade of immune checkpoints are under evaluation in patients with brain cancer. Here we summarize clinically significant imaging findings such as treatment-related changes detected by advanced neuroimaging techniques following the most suitable immunotherapy options currently used in neuro-oncology. We, furthermore, provide an overview of how these advanced imaging techniques may help to overcome shortcomings of standard MRI in the assessment and follow-up of patients with brain cancer. Areas covered: The current literature on neuroimaging for immunotherapy in the field of brain tumors, with a focus on gliomas and brain metastases is summarized. Expert commentary: Data suggest that imaging parameters primarily derived from amino acid PET, diffusion- and perfusion-weighted MRI, or MR spectroscopy are particularly helpful for the evaluation of treatment response and provide valuable information for the differentiation of treatment-induced changes from actual brain tumor progression following various immunotherapy approaches.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Galldiks, NorbertUNSPECIFIEDorcid.org/0000-0002-2485-1796UNSPECIFIED
Lohmann, PhilippUNSPECIFIEDorcid.org/0000-0002-5360-046XUNSPECIFIED
Werner, Jan-MichaelUNSPECIFIEDorcid.org/0000-0001-7147-4594UNSPECIFIED
Ceccon, GarryUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fink, Gereon R.UNSPECIFIEDorcid.org/0000-0002-8230-1856UNSPECIFIED
Langen, Karl-JosefUNSPECIFIEDorcid.org/0000-0003-1101-5075UNSPECIFIED
URN: urn:nbn:de:hbz:38-124081
DOI: 10.1080/14737140.2020.1705788
Journal or Publication Title: Expert Rev. Anticancer Ther
Volume: 20
Number: 1
Page Range: S. 9 - 16
Date: 2020
Publisher: TAYLOR & FRANCIS LTD
Place of Publication: ABINGDON
ISSN: 1744-8328
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
POSITRON-EMISSION-TOMOGRAPHY; RESPONSE ASSESSMENT; GENE-EXPRESSION; GLIOBLASTOMA; THERAPY; PET; PSEUDOPROGRESSION; RECOMMENDATIONS; METASTASIS; PROSPECTSMultiple languages
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/12408

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item